Translational and clinical immunologyAutoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies
Section snippets
Methods
We systematically screened patients with PIDs living in France for the occurrence of autoimmune or inflammatory complications (see Table E1 in this article's Online Repository at www.jacionline.org). Data were consecutively collected between September 1, 2013, and February 1, 2016, on 2183 patients either on initial registration in the CEREDIH database (hosted by the secured online ESID Registry, see www.esid.org) or during follow-up of previously registered patients.3 All of the data were
Overall frequency and distribution of autoimmune and inflammatory conditions
Of the 2183 surveyed patients (median age, 20 years; mean age, 25.8 years; range, 0.5-92 years), 571 (26.2%) had at least 1 autoimmune or inflammatory condition. The wide range of manifestations (n = 852) encompassed most of the known autoimmune diseases (Tables I and II and see Table E1), with the notable predominance of autoimmune cytopenia (mostly anemia, n = 110 manifestations), thrombocytopenia (n = 130 manifestations), or both. When comparing the study population with the general
Discussion
The present retrospective study is the first to report the frequency and distribution of autoimmune and inflammatory manifestations in a group of patients with PIDs. The study's nature (ie, retrospective and cross-sectional) was associated with some obvious limitations, despite the fact it is supported by a national registry. Given the importance of providing optimal care for patients with PIDs, our present results should be viewed as an incentive to launch a prospective analysis of
References (32)
- et al.
Primary immunodeficiencies in the Netherlands: national patient data demonstrate the increased risk of malignancy
Clin Immunol
(2015) - et al.
Food allergy in patients with primary immunodeficiency diseases: prevalence within the US Immunodeficiency Network (USIDNET)
J Allergy Clin Immunol
(2015) - et al.
Autoimmune disease in primary immunodeficiency: at the crossroads of anti-infective immunity and self-tolerance
Immunol Allergy Clin North Am
(2015) - et al.
The crossroads of autoimmunity and immunodeficiency: Lessons from polygenic traits and monogenic defects
J Allergy Clin Immunol
(2016) - et al.
Inflammatory manifestations in a single-center cohort of patients with chronic granulomatous disease
J Allergy Clin Immunol
(2014) - et al.
Updated assessment of the prevalence, spectrum and case definition of autoimmune disease
Autoimmun Rev
(2012) - et al.
The epidemiology of autoimmune diseases
Autoimmun Rev
(2003) - et al.
Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases
J Autoimmun
(2009) - et al.
Google-driven search for big data in autoimmune geoepidemiology: analysis of 394,827 patients with systemic autoimmune diseases
Autoimmun Rev
(2015) - et al.
Gender-specific incidence of autoimmune diseases from national registers
J Autoimmun
(2016)
Epidemiology of autoimmune diseases in Denmark
J Autoimmun
Defining and analyzing geoepidemiology and human autoimmunity
J Autoimmun
Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France
Blood
Epidemiology of inflammatory bowel diseases: new insights from a French population-based registry (EPIMAD)
Dig Liver Dis
Live rubella virus vaccine long-term persistence as an antigenic trigger of cutaneous granulomas in patients with primary immunodeficiency
Clin Microbiol Infect
Primary immunodeficiency syndrome in Spain: first report of the National Registry in Children and Adults
J Clin Immunol
Cited by (228)
The chemokine XCL1 functions as a pregnancy hormone to program offspring innate anxiety
2024, Brain, Behavior, and ImmunityThe autoimmune rheumatological presentation of Common Variable Immunodeficiency Disorders with an overview of genetic testing
2024, Seminars in Arthritis and RheumatismMultilayer concept of autoimmune mechanisms and manifestations in inborn errors of immunity: Relevance for precision therapy
2024, Journal of Allergy and Clinical ImmunologyCutaneous Findings in Inborn Errors of Immunity: An Immunologist's Perspective
2023, Journal of Allergy and Clinical Immunology: In Practice
CEREDIH is supported by the French Association of Patients with Primary Immunodeficiencies (IRIS) and is funded by the French Ministry of Health. It additionally received unrestricted educational grants from LFB, GlaxoSmithKline, CSL Behring, Baxalta, Octapharma, Binding Site, and the patient associations AT-Europe and Trophée Guillaume.
Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest.
- ∗
Members of the Centre de Référence Déficits Immunitaires Héréditaires (CEREDIH), France: Daniel Adoue, MD; Nathalie Aladjidi, MD; Zahir Amoura, MD; Philippe Arlet, MD; Corinne Armari-Alla, MD; Brigitte Bader-Meunier, MD; Vincent Barlogis, MD; Sophie Bayart, MD; Beatrice Beaurain, BS; Yves Bertrand, MD, PhD; Boris Bienvenu, MD; Stéphane Blanche, MD; Damien Bodet, MD; Bernard Bonnotte, MD; Raphaël Borie, MD; Patrick Boutard, MD; Claire Briandet, MD; Jean-Paul Brion, MD; Carolina Brito, MSc; Jacques Brouard, MD; Emilie Catherinot, MD, PhD; Olivia Chandesris, MD; Sarah Cohen-Beaussant, MD; Hélène Coignard-Biehler, MD; Laurence Costes, BS; Louis-Jean Couderc, MD; Gérard Couillault, MD; Virginie Courteille, BS; Elodie Curlier, MD; Geneviève de Saint Basile, MD, PhD; François Demeocq, MD; Nathalie de Vergnes, BS; Catherine Devoldere, MD; Anne Deville, MD; Jean Donadieu, MD; Eric Dore, MD; Fabienne Dulieu, MD; Isabelle Durieu, MD; Christine Edan, MD; Natacha Entz Werle, MD; Claire Fieschi, MD, PhD; Fanny Fouyssac, MD; Pierre Frange, MD, PhD; Vincent Gajdos, MD, PhD; Lionel Galicier, MD; Virginie Gandemer, MD, PhD; Martine Gardembas, MD; Catherine Gaud, MD; Bernard Grosbois, MD; Gaelle Guillerm, MD; Eric Hachulla, MD; Mohamed Hamidou, MD; Sébastien Héritier, MD; Olivier Hermine, MD, PhD; Cyrille Hoarau, MD; Bruno Hoen, MD; Arnaud Hot, MD, PhD; Sébastien Humbert, MD; Arnaud Jaccard, MD; Serge Jacquot, MD; Jean-Philippe Jais, MD, PhD; Rolland Jaussaud, MD; Pierre-Yves Jeandel, MD; Eric Jeziorski, MD, PhD; Kamila Kebaili, MD; Anne-Sophie Korganow, MD; Philippe Labrune, MD; Olivier Lambotte, MD, PhD; Fanny Lanternier, MD, PhD; Claire Larroche, MD; Alain Le Quellec, MD; Emmanuelle Le Moigne, MD; Vincent Le Moing, MD; Yvon Lebranchu, MD; Marc Lecuit, MD, PhD; Guillaume Lefevre, MD; Richard Lemal, MD; Philippe Le Moine, MD; Valérie Li Thiao Te, MD; Olivier Lortholary, MD, PhD; Patrick Lutz, MD; Aude Magerus-Chatinet, PhD; Marion Malphettes, MD; Aude Marie-Cardine, MD; Nicolas Martin Silva, MD; Agathe Masseau, MD; Christian Massot, MD; Françoise Mazingue, MD; Etienne Merlin, MD; Gérard Michel, MD; Frédéric Millot, MD; Odile Minckes, MD; Béatrice Monlibert, MD; Fabrice Monpoux, MD, PhD; Despina Moshous, MD, PhD; Luc Mouthon, MD; Martine Munzer, MD; Bénédicte Neven, MD, PhD; Raphaëlle Nove-Josserand, MD; Eric Oksenhendler, MD, PhD; Marie Ouachée-Chardin, MD; Anne Pagnier, MD; Jean-Louis Pasquali, MD, PhD; Marlène Pasquet, MD; Isabelle Pellier, MD, PhD; Yves Perel, MD; Antoinette Perlat, MD; Capucine Picard, MD, PhD; Christophe Piguet, MD; Dominique Plantaz, MD; Pierre Quartier, MD; Frédéric Rieux-Laucat, PhD; Pascal Roblot, MD; Pierre-Marie Roger, MD; Pierre-Simon Rohrlich, MD; Bruno Royer, MD; Valéry Salle, MD; Françoise Sarrot-Reynauld, MD; Amélie Servettaz, MD; Jean-Louis Stephan, MD; Nicolas Schleinitz, MD; Felipe Suarez, MD, PhD; Laure Swiader, MD; Sophie Taque, MD; Caroline Thomas, MD; Olivier Tournilhac, MD; Caroline Thumerelle, MD; Jean-Pierre Vannier, MD; and Jean-François Viallard, MD.